.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Baxter
Medtronic
AstraZeneca
Federal Trade Commission
McKesson
US Army
Express Scripts
Novartis
Harvard Business School

Generated: June 28, 2017

DrugPatentWatch Database Preview

Quinapril hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for quinapril hydrochloride and what is the scope of quinapril hydrochloride freedom to operate?

Quinapril hydrochloride
is the generic ingredient in two branded drugs marketed by Sun Pharm Inds Ltd, Sandoz, Teva, Prinston Inc, Aurobindo Pharma Ltd, Mylan, Apotex Inc, Actavis Labs Fl Inc, Invagen Pharms, Actavis Elizabeth, Pfizer Pharms, and Lupin, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for quinapril hydrochloride. Twenty-one suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: quinapril hydrochloride

Tradenames:2
Patents:1
Applicants:12
NDAs:14
Drug Master File Entries: see list11
Suppliers / Packagers: see list21
Bulk Api Vendors: see list34
Clinical Trials: see list2,263
Patent Applications: see list2,088
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:quinapril hydrochloride at DailyMed

Pharmacology for Ingredient: quinapril hydrochloride

Tentative approvals for QUINAPRIL HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 5MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 40MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 20MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL076049-003Jan 14, 2005DISCNNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL202725-003Apr 29, 2013ABRXNoNo► Subscribe► Subscribe
Actavis Elizabeth
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL076459-004Dec 22, 2004DISCNNoNo► Subscribe► Subscribe
Mylan
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL076036-001Jan 28, 2005DISCNNoNo► Subscribe► Subscribe
Invagen Pharms
QUINAPRIL HYDROCHLORIDE
quinapril hydrochloride
TABLET;ORAL078457-003Aug 24, 2007ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: quinapril hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-004Nov 19, 19914,743,450*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-004Nov 19, 19915,684,016*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-001Nov 19, 19915,747,504*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-003Nov 19, 19915,684,016*PED► Subscribe
Pfizer Pharms
ACCUPRIL
quinapril hydrochloride
TABLET;ORAL019885-002Nov 19, 19914,743,450*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Moodys
Accenture
Medtronic
UBS
Fuji
Express Scripts
Merck
Dow
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot